Liverpool Partners may seek backer for Genea
Speculation is mounting that Genea could be the next healthcare business to hit the market, with owner Liverpool Partners likely to be looking for a financial backer.
Speculation is mounting that Genea could be the next healthcare business to hit the market, with owner Liverpool Partners likely to be looking for a financial backer.
CoStar founder and president Andrew Florance is understood to have been in Australia late in 2024 as part of his quest to gain control of Domain Group, sources say.
Two listed powerhouses, Origin Energy and Goodman Group, could both have their sights on major demergers or spin-offs of units in the coming years.
A move by BlueScope to manage the Whyalla steelworks on behalf of the government could be stage one of a long-term plan to find a solution for the troublesome operation, sources say.
CoStar has raided Domain Group, with Macquarie Securities amassing up to 10 per cent of the stock.
The dealmaker is the first among the top ranks to leave the Australian investment firm since its launch.
Light and Wonder is believed to have fended off competition for Grover Gaming from groups including the Australian-listed Aristocrat Leisure and Churchill Downs Incorporated.
About 30 parties are so far interested in Fonterra’s valuable portfolio of dairy brands that it has placed up for sale.
A nationalisation of Australia’s most strategic steel making asset could be on the cards with the country’s industry champion playing a role.
The country’s largest listed industrial property owner is calling on investors to take part in the biggest cash call in over a year.
More details are filtering out into the market surrounding takeover attempts for Healthscope, with Bupa supposedly interested in operating hospitals in its portfolio.
There’s some suggestion that KKR could make a bid for all of Perpetual, then return the asset management arm back to shareholders by way of an in specie distribution to get around the company’s onerous tax costs.
Private equity funds have set their sights on business-to-business or business-to-government service providers when it comes to acquisitions, and reporting season so far is demonstrating why.
The dairy giant is calling for suitors to run the ruler over its Australia and New Zealand dairy brands.
A decision by Kohlberg Kravis Roberts to sweeten the deal for Perpetual’s corporate trust and wealth management units comes after the shares of the financial group have rallied this year.
Engineering firm Worley could be in sharp focus for deal-makers next week when the group reports its half-year results, as its major global competitor, Wood, comes under intense pressure.
The fallout of the GFG Alliance, controlled by Sanjeev Gupta, is linked to outstanding debts to customers from South Australia’s major steelworks.
The casino operator’s key lenders are refusing to bow to pressure to offload their loans at steep discounts.
Coal mining investor AMCI is offloading an interest in its Fitzroy mining complex in a quest to attract an investment worth about $100m.
Data centres are in strong demand from investors, and asset owners are cashing in.
Perpetual’s negotiations over the sale of its corporate trust and wealth management units to Kohlberg Kravis Roberts may be close to ending as KKR returns with an improved offer.
The woes around cash-strapped Healthscope have prompted private equity firms to pay closer attention to its larger rival Ramsay Health Care, which could shape up as a major winner should the former collapse.
The listed real estate group says all options are on the table for ensuring its major hospital tenant keeps trading.
The $1.7bn Domain Group is said to have been shopped to private equity firms far and wide to test their interest in taking a stake in the business. None appear keen, sources say.
There are rumblings across the Tasman over the state of New Zealand’s media industry, and some wealthy Kiwis are said to be plotting to do something about it.
Two of the country’s top pathology services providers, Healius and Australian Clinical Labs, are understood to have resumed talks about a potential $2bn tie-up, say market sources.
Brookfield is ringing the changes at the top of its embattled private hospital operator Healthscope, with a top restructuring expert taking the reins as its next chief executive.
The real test for the shareholder popularity of Chemist Warehouse begins Thursday.
How the combined group trades depends on how many pharmacy owners cash in on day one.
The sale is shaping up to be one of the largest auctions for an Australian healthcare business this year.
Original URL: https://www.theaustralian.com.au/business/dataroom/page/6